PHARMAOUEST IND is an exporter focused on specialty chemical and pharmaceutical intermediates, principally classified under HS 2244 (organic ammonium compounds). The firm’s recorded activity shows a single, high‑value shipment in December 2021: 244 kg (≈1 TEU) from Le Havre, France to the New York/Newark area, delivered to buyer DROSERA SAS. For prospective buyers, PHARMAOUEST IND demonstrates capability to source niche pharma‑grade chemicals from a major French gateway, with a clean, one‑off shipment evidencing precise product handling and reliable partner coordination. The limited but transparent transaction history suggests a cautious but dependable supply profile, suitable for niche demand spikes. Customs brokers will note consistent documentation using HS 2244, straightforward routing via a single European loading port and a single US entry point, and a modest cargo size that typically incurs fast clearance and low inspection risk. Overall, the company offers a focused, compliant export pipeline that can be leveraged for targeted pharmaceutical ingredient procurement while ensuring predictable customs processing.